ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Lists ARRA Funding By Organ Site

September 18, 2009

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979